Errors in Table 2 and Figure 2
- PMID: 31913428
- PMCID: PMC6990760
- DOI: 10.1001/jamadermatol.2019.4551
Errors in Table 2 and Figure 2
Erratum for
-
Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial.JAMA Dermatol. 2019 Dec 1;155(12):1371-1379. doi: 10.1001/jamadermatol.2019.2855. JAMA Dermatol. 2019. PMID: 31577341 Free PMC article. Clinical Trial.
